IN2009DN07390A - - Google Patents
Download PDFInfo
- Publication number
- IN2009DN07390A IN2009DN07390A IN7390DEN2009A IN2009DN07390A IN 2009DN07390 A IN2009DN07390 A IN 2009DN07390A IN 7390DEN2009 A IN7390DEN2009 A IN 7390DEN2009A IN 2009DN07390 A IN2009DN07390 A IN 2009DN07390A
- Authority
- IN
- India
- Prior art keywords
- human
- tissues
- derived therefrom
- cells derived
- relates
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 101100187477 Homo sapiens NR1I2 gene Proteins 0.000 abstract 1
- 102000003839 Human Proteins Human genes 0.000 abstract 1
- 108090000144 Human Proteins Proteins 0.000 abstract 1
- 108091092195 Intron Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 235000021120 animal protein Nutrition 0.000 abstract 1
- 230000036267 drug metabolism Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/80—Cytochromes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0393—Animal model comprising a reporter system for screening tests
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/757,972 US7759541B2 (en) | 2004-12-13 | 2007-06-04 | Transgenic animals for assessing drug metabolism and toxicity |
| PCT/GB2008/001897 WO2008149080A1 (en) | 2007-06-04 | 2008-06-04 | Transgenic animals for assessing drug metabolism and toxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2009DN07390A true IN2009DN07390A (enExample) | 2015-07-24 |
Family
ID=39698732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7390DEN2009 IN2009DN07390A (enExample) | 2007-06-04 | 2008-06-04 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7759541B2 (enExample) |
| EP (1) | EP2173160A1 (enExample) |
| JP (1) | JP2010528644A (enExample) |
| AU (1) | AU2008259618A1 (enExample) |
| CA (1) | CA2688438A1 (enExample) |
| IL (1) | IL202127A0 (enExample) |
| IN (1) | IN2009DN07390A (enExample) |
| WO (1) | WO2008149080A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7759541B2 (en) | 2004-12-13 | 2010-07-20 | Iti Life Sciences | Transgenic animals for assessing drug metabolism and toxicity |
| JP4997544B2 (ja) * | 2007-11-14 | 2012-08-08 | 国立大学法人鳥取大学 | ヒトチトクロームp450遺伝子(クラスター)を含む哺乳動物人工染色体ベクター及びそれを保持する非ヒト哺乳動物 |
| CA3040377C (en) | 2009-10-06 | 2025-12-30 | Yale University | Genetically modified mice and engraftment comprising the knock-in of a human thrombopoietin (tpo) gene |
| WO2011160573A1 (zh) * | 2010-06-21 | 2011-12-29 | 中国科学院上海生命科学研究院 | 一种生产高活性和高纯度利福霉素sv的方法 |
| US20120023599A1 (en) * | 2010-07-23 | 2012-01-26 | Sigma-Aldrich Co. | Genome editing of cytochrome p450 in animals |
| ES3040596T3 (en) | 2011-02-15 | 2025-11-03 | Regeneron Pharma | Humanized m-csf mice and uses thereof |
| FR2979453B1 (fr) * | 2011-08-26 | 2016-01-08 | Olea Medical | Systeme et procede pour estimer une quantite d'interet d'un systeme dynamique artere/tissu/veine |
| MY186903A (en) | 2011-10-28 | 2021-08-26 | Regeneron Pharma | Humanized il-6 and il-6 receptor |
| US8962913B2 (en) | 2012-06-18 | 2015-02-24 | Regeneron Pharmaceuticals, Inc. | Humanized IL-7 rodents |
| KR102287541B1 (ko) | 2012-09-07 | 2021-08-10 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| EP4389764B1 (en) * | 2012-11-05 | 2026-03-18 | Regeneron Pharmaceuticals, Inc. | Genetically modified rodents and methods of use thereof |
| US20140273031A1 (en) * | 2013-03-15 | 2014-09-18 | The Cleveland Clinic Foundation | In-vitro method for monoclonal antibody production |
| SMT201900177T1 (it) * | 2013-10-15 | 2019-05-10 | Regeneron Pharma | Animali con il-15 umanizzata |
| CN105792646B (zh) * | 2013-11-19 | 2018-03-02 | 瑞泽恩制药公司 | 具有人源化的b细胞活化因子基因的非人动物 |
| SG10201811701YA (en) * | 2013-11-19 | 2019-01-30 | Regeneron Pharma | Non-human animals having a humanized a proliferation-inducing ligand gene |
| US9665718B2 (en) | 2014-03-14 | 2017-05-30 | International Business Machines Corporation | Correlating a task with commands to perform a change ticket in an IT system |
| KR20250096864A (ko) | 2014-05-19 | 2025-06-27 | 리제너론 파마슈티칼스 인코포레이티드 | 인간 epo를 발현하는 유전자 변형된 비-인간 동물 |
| JP6752221B2 (ja) | 2015-04-13 | 2020-09-09 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化sirpa−il15ノックインマウス及びその使用方法 |
| CN114875066A (zh) | 2016-06-27 | 2022-08-09 | 贝勒医学院 | 具有缺陷性p450氧化还原酶的人肝嵌合非人动物及其使用方法 |
| CN109182292B (zh) * | 2018-09-25 | 2022-02-08 | 安徽农业大学 | 一种草莓谷胱甘肽转移酶FaGST基因及其表达蛋白和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6476000A (en) | 1999-08-13 | 2001-03-13 | Kirin Beer Kabushiki Kaisha | Mouse having human cytochrome p450 transferred therein |
| EP1088900A1 (en) | 1999-09-10 | 2001-04-04 | Epidauros Biotechnologie AG | Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| WO2002036784A1 (en) | 2000-11-01 | 2002-05-10 | The University Of Sydney | Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| AUPR446701A0 (en) | 2001-04-18 | 2001-05-17 | Gene Stream Pty Ltd | Transgenic mammals for pharmacological and toxicological studies |
| JP2003304896A (ja) | 2002-04-15 | 2003-10-28 | Yasushi Yamazoe | ヒトcyp3a誘導能の測定法 |
| GB0216203D0 (en) | 2002-07-12 | 2002-08-21 | Imp Cancer Res Tech | Mondulation of cytochrome P450 reductase activity |
| AU2003278790A1 (en) * | 2002-09-09 | 2004-03-29 | California Institute Of Technology | Methods and compositions for the generation of humanized mice |
| ES2391099T3 (es) * | 2004-12-13 | 2012-11-21 | Iti Scotland Limited | Animales transgénicos para evaluar el metabolismo y la toxicidad de un fármaco |
| US7759541B2 (en) | 2004-12-13 | 2010-07-20 | Iti Life Sciences | Transgenic animals for assessing drug metabolism and toxicity |
-
2007
- 2007-06-04 US US11/757,972 patent/US7759541B2/en not_active Expired - Fee Related
-
2008
- 2008-06-04 EP EP08762250A patent/EP2173160A1/en not_active Withdrawn
- 2008-06-04 JP JP2010510871A patent/JP2010528644A/ja active Pending
- 2008-06-04 WO PCT/GB2008/001897 patent/WO2008149080A1/en not_active Ceased
- 2008-06-04 AU AU2008259618A patent/AU2008259618A1/en not_active Abandoned
- 2008-06-04 CA CA002688438A patent/CA2688438A1/en not_active Abandoned
- 2008-06-04 US US12/602,723 patent/US8624079B2/en not_active Expired - Fee Related
- 2008-06-04 IN IN7390DEN2009 patent/IN2009DN07390A/en unknown
-
2009
- 2009-11-15 IL IL202127A patent/IL202127A0/en unknown
-
2010
- 2010-05-26 US US12/787,816 patent/US8212105B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20100235928A1 (en) | 2010-09-16 |
| US7759541B2 (en) | 2010-07-20 |
| US8212105B2 (en) | 2012-07-03 |
| AU2008259618A1 (en) | 2008-12-11 |
| WO2008149080A1 (en) | 2008-12-11 |
| US20080148416A1 (en) | 2008-06-19 |
| JP2010528644A (ja) | 2010-08-26 |
| US20100257620A1 (en) | 2010-10-07 |
| CA2688438A1 (en) | 2008-12-11 |
| US8624079B2 (en) | 2014-01-07 |
| IL202127A0 (en) | 2010-06-16 |
| EP2173160A1 (en) | 2010-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2009DN07390A (enExample) | ||
| EP2172549A3 (en) | RNAi expression constructs | |
| WO2009007855A3 (en) | Reversible sirna-based silencing of mutant and endogenous wild-type huntingtin gene and its application for the treatment of huntington's disease | |
| Sabourdy et al. | Functions of sphingolipid metabolism in mammals—lessons from genetic defects | |
| SG158158A1 (en) | Glp-1 agonists, compositions, methods and uses | |
| EP2302034A3 (en) | Improved methods of reprogramming animal somatic cells | |
| WO2008054466A3 (en) | Delivery of biologically active materials using core-shell tecto (dendritic polymers) | |
| WO2007118245A8 (en) | Methods and compositions related to adenoassociated virus-phage particles | |
| WO2007035213A3 (en) | Transgenic ungulates expressing ctla4-ig and uses thereof | |
| WO2006001021A3 (en) | Chimeric avian-based screening system containing mammalian grafts | |
| WO2008153743A3 (en) | Compositions and methods for cancer gene discovery | |
| WO2006047603A3 (en) | Ungulates with genetically modified immune systems | |
| WO2006064197A3 (en) | Transgenic animals for assessing drug metabolism and toxicity | |
| WO2004108904A3 (en) | Porcine cmp-n-acetylneuraminic acid hydroxylase gene | |
| MX2012000918A (es) | Sistema y metodo para la alimentacion de insectos beneficosos. | |
| BRPI0510206A (pt) | método de identificação de fenótipo, célula isolada, métodos de identificação de agentes, agentes, agentes terapêuticos, método de avaliação de agente terapêutico, composição farmacêutica, métodos de tratamento, prevenção ou melhoria de disfunções e métodos de modulação | |
| WO2008099280A3 (en) | Regulation of expression of pi3kb protein in tumors | |
| IL274740B2 (en) | Non-human animals comprising a humanized trkb locus | |
| WO2005047469A3 (en) | PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION | |
| NZ598769A (en) | Transgenic chickens | |
| Garrott et al. | The Madison Headwaters elk herd: transitioning from bottom–up regulation to top–down limitation | |
| WO2005111204A3 (en) | Porcine forssman synthetase cdna and polypeptide | |
| WO2006074012A3 (en) | Facilitated cellular reconstitution of organs and tissues | |
| HK1140912A (en) | Transgenic animals for assessing drug metabolism and toxicity | |
| DE60002603D1 (de) | Phosphor-enthaltende dendrimere als transfektionsagente |